Ito S, Oki E, Nakashima Y, Ando K, Hiyoshi Y, Ohgaki K, Saeki H, Morita M, Sakaguchi Y, Maehara Y. Clinical significance of adjuvant surgery following chemotherapy for patients with initially unresectable stage IV gastric cancer. Anticancer Res. 2015;35:401–6.
Kanda T, Yajima K, Kosugi S, Ishikawa T, Ajioka Y, Hatakeyama K. Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective study. Gastric Cancer. 2012;15:235–44.
Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N. A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data. Gastric Cancer. 2020;23:510–9.
Article CAS PubMed Google Scholar
JGC Association. Japanese classification of gastric carcinoma: 3rd english edition. Gastric Cancer. 2011;14:101–12.
Bearz A, Perin T, Cancian L, Berto E, Sartor I, Tirelli U. Immune checkpoint inhibitors and response analysis: a tough challenge. A case report. BMC Res Notes. 2016;9:349.
Article PubMed PubMed Central Google Scholar
Kinoshita T, Kinoshita T, Saiura A, Esaki M, Sakamoto H, Yamanaka T. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases. Br J Surg. 2015;102:102–7.
Article CAS PubMed Google Scholar
Oki E, Tokunaga S, Emi Y, Kusumoto T, Yamamoto M, Fukuzawa K, Takahashi I, Ishigami S, Tsuji A, Higashi H, Nakamura T, Saeki H, Shirabe K, Kakeji Y, Sakai K, Baba H, Nishimaki T, Natsugoe S, Maehara Y. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302). Gastric Cancer. 2016;19:968–76.
Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19:329–38.
Matsumoto R, Arigami T, Matsushita D, Okubo K, Tanaka T, Yanagita S, Sasaki K, Noda M, Kita Y, Mori S, Kurahara H, Ohtsuka T. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report. World J Surg Oncol. 2020;18:179.
Article PubMed PubMed Central Google Scholar
Japanese gastric cancer treatment guidelines. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2018;24:1–21.
Hirata K, Tamaki N. Quantitative FDG PET assessment for oncology therapy. Cancers (Basel). 2021;13:869.
Article CAS PubMed Google Scholar
Vitolo U, Trněný M, Belada D, Burke JM, Carella AM, Chua N, Abrisqueta P, Demeter J, Flinn I, Hong X, Kim WS, Pinto A, Shi YK, Tatsumi Y, Oestergaard MZ, Wenger M, Fingerle-Rowson G, Catalani O, Nielsen T, Martelli M, Sehn LH. Obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated diffuse large B-cell lymphoma. J Clin Oncol. 2017;35:3529–37.
Article CAS PubMed Google Scholar
Dai P, Rao X, Zhang X, Qiu E, Wu G, Lin Y, Li S, Li Z, Cai Z, Han S. Case report: complete remission of a patient with metastatic gastric cancer treated with nivolumab combined with chemotherapy after palliative surgery. Front Immunol. 2022;13: 908558.
Article CAS PubMed PubMed Central Google Scholar
Toyota K, Hashimoto Y, Sakashita Y, Yokoyama Y, Murakami Y, Takahashi S, Miyamoto K. Pathological complete response to Nivolumab, S1, Oxaliplatin, and radiation in a patient with gastric cancer: a case report. J Gastrointest Cancer. 2022. https://doi.org/10.1007/s12029-022-00895-z.
Pan Y, Lu L, Liu H, Chen D, Han N, Yao R, Wang X, Gao X, Yu J, Chen L, Zhou F, Hao G, Lu Y, Li M, He G, Kang F, Li Z, Tang Y, Zhang J, Wei L, Nie Y. Case report: Long response to PD-1 blockade after failure of trastuzumab plus chemotherapy in advanced Epstein-Barr virus-associated gastric cancer. Front Immunol. 2022;13:1003859.
Article CAS PubMed PubMed Central Google Scholar
Takami T, Yasuda K, Uozumi N, Musiake Y, Shintani H, Kataoka N, Yamaguchi T, Makimoto S. Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report. J Med Case Rep. 2021;15:604.
Article PubMed PubMed Central Google Scholar
Watanabe H, Fujikawa H, Komori K, Kano K, Takahashi K, Yamada T, Inokuchi Y, Machida N, Yokose T, Rino Y, Masuda M, Ogata T, Oshima T. Successful conversion surgery for stage IV gastric cancer after nivolumab monotherapy as third-line chemotherapy. Case Rep Gastroenterol. 2021;15:562–7.
Article PubMed PubMed Central Google Scholar
Kumamoto T, Tomita T, Hojo Y, Nakamura T, Kurahashi Y, Ishida Y, Miwa H, Hirota S, Shinohara H. Pathological complete response and successful conversion surgery after nivolumab therapy for stage IV oesophagogastric junction cancer. In Vivo. 2021;35:2247–51.
Article PubMed PubMed Central Google Scholar
Komo T, Suzuki T, Tazawa H, Sada H, Morimoto H, Shimada N, Hadano N, Onoe T, Sudo T, Shimizu Y, Tashiro H. Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: a case report. Int J Surg Case Rep. 2021;84: 106161.
Article PubMed PubMed Central Google Scholar
Kuhara Y, Ninomiya M, Hirahara S, Doi H, Kenji S, Toyota K, Yano R, Kobayashi H, Hashimoto Y, Yokoyama Y, Sakashita Y, Miyamoto K. A long-term survival case of unresectable gastric cancer with multidisciplinary therapy including immunotherapy and abscopal effect. Int Cancer Conf J. 2020;9:193–8.
Article PubMed PubMed Central Google Scholar
Toyota S, Orita H, Fukuyama Y, Motoyoshi S, Kawanami S, Maeda S, Kuramitsu E, Ichimanda M, Nagamatsu S, Nagata S, Kai S, Korenaga D, Mori M. Successful conversion surgery following chylous ascites after nivolumab for advanced gastric cancer. In Vivo. 2020;34:583–5.
Article PubMed PubMed Central Google Scholar
Toyota S, Naito H, Motoyoshi S, Nakanishi R, Oki E, Orita H, Korenaga D. Extended total gastrectomy after nivolumab for unresectable multivisceral invasive gastric cancer. Surg Case Rep. 2020;6:298.
Article PubMed PubMed Central Google Scholar
Kashima S, Tanabe H, Tanino M, Kobayashi Y, Murakami Y, Iwama T, Sasaki T, Kunogi T, Takahashi K, Ando K, Ueno N, Moriichi K, Fukudo M, Tasaki Y, Hosokawa M, Mizukami Y, Fujiya M, Okumura T. Lymph node metastasis from gastroesophageal cancer successfully treated by nivolumab: a case report of a young patient. Front Oncol. 2019;9:1375.
Article PubMed PubMed Central Google Scholar
Namikawa T, Ishida N, Tsuda S, Fujisawa K, Munekage E, Iwabu J, Munekage M, Uemura S, Tsujii S, Maeda H, Kitagawa H, Kobayashi M, Hanazaki K. Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab. Surg Case Rep. 2018;4:71.
留言 (0)